Overview

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Status:
Not yet recruiting
Trial end date:
2026-04-23
Target enrollment:
Participant gender:
Summary
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD
Treatments:
Tofacitinib